Skip to content

Changes in High Sensitive C Reactive Protien With Different Treatment Modalities in Acute Pancreatitis

Changes in High Sensitive C Reactive Protien With Different Treatment Modalities in Acute Pancreatitis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03740685
Enrollment
80
Registered
2018-11-14
Start date
2018-11-09
Completion date
2019-10-08
Last updated
2018-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatitis, Acute

Brief summary

changes in high sensitive C reactive protien with different treatment modalities in acute pancreatitis

Interventions

DIAGNOSTIC_TESTHigh sesitive C reactive protien

High sesitive C reactive protien will be evaluated at admission time and after 36 hours

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age\>=18 years * Diagnosis of acute pancreatitis confirmed by at least 2 of the following: 1. Typical epigastric abdominal pain 2. Elevation amylase/lipase \>3 times upper limit normal and/or 3. Confirmatory findings on cross-sectional imaging 4. Enrollment within 8 hours of presentation

Exclusion criteria

* Class II or greater NYHA heart failure * Oxygen dependent COPD * Chronic kidney disease\>stage 2 * Existing necrosis on abdominal CT * Organ dysfunction prior to enrollment * Sepsis * Acute respiratory distress syndrome * Malignancy not in remission for at least 5 years * Active drug use * Known allergy to dexamethasone * Altered mental status * Insulin-requiring diabetes * Abdominal surgery within 60days

Design outcomes

Primary

MeasureTime frameDescription
High sesitive C reactive protien72hoursLevel of High sesitive C reactive protien expected to be changed with different lines of treatment and will be compaered
Serum Amylase72hoursLevel of Serum Amylase expected to be changed with different lines of treatment and will be compaered
Serum Lipase72hoursLevel of Serum Lipase expected to be changed with different lines of treatment and will be compaered

Countries

Egypt

Contacts

Primary Contactmahmoud Abd Elhamed, principal participant
mahmoudsisi100@yahoo.com01017141345

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026